Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.

Three biotech stocks in the IBD 50 are setting up in bases while a fourth is pulling back from highs as the first-quarter earnings season gets into full swing. Travere TherapeuticsTVTX, part of IBD's ...

Novo Nordisk, Regeneron, and Vertex lead the 10 biggest biotech companies list Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, ...

In this article, we will be taking a look at the 8 Oversold Biotech Stocks to Invest In Now. On February 5, J.P. Morgan revealed major themes that are expected to affect healthcare in 2026, ...

On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...

The Stocks: Vertex Pharmaceuticals (VRTX) trades at 22.9x forward P/E with 0.30 beta despite a flat two-year performance. Regeneron (REGN) has crashed 48% from its 2024 high following Fianlimab ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

If you're looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that mega-cap AI IPO boom on the horizon, with SpaceX leading the way, the biotech ...